These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16929357)

  • 1. Mineralocorticoid-receptor blockade, hypertension and heart failure.
    Funder JW
    Nat Clin Pract Endocrinol Metab; 2005 Nov; 1(1):4-5. PubMed ID: 16929357
    [No Abstract]   [Full Text] [Related]  

  • 2. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.
    Moore TD; Nawarskas JJ; Anderson JR
    Heart Dis; 2003; 5(5):354-63. PubMed ID: 14503934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone antagonists in heart failure.
    Guglin M; Kristof-Kuteyeva O; Novotorova I; Pratap P
    J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):150-9. PubMed ID: 21160084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eplerenone and chronic heart failure. No comparison with spironolactone.
    Prescrire Int; 2013 Jun; 22(139):148-9. PubMed ID: 23866347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug insight: aldosterone-receptor antagonists in heart failure--the journey continues.
    Kalidindi SR; Tang WH; Francis GS
    Nat Clin Pract Cardiovasc Med; 2007 Jul; 4(7):368-78. PubMed ID: 17589427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone target organ protection by eplerenone.
    Rudolph AE; Rocha R; McMahon EG
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):229-38. PubMed ID: 15134822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone antagonists: a new treatment option for patients with post-myocardial infarction heart failure.
    Ajani AE; Marwick TH; Krum H
    Cardiovasc Revasc Med; 2006; 7(4):234-6. PubMed ID: 17174870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of aldosterone receptor blockade in the management of cardiovascular disease.
    Liew D; Krum H
    Curr Opin Investig Drugs; 2002 Oct; 3(10):1468-73. PubMed ID: 12431020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selective aldosterone blocker for hypertension and heart failure. Better tolerance than previous drugs].
    MMW Fortschr Med; 2002 Sep; 144(39):50. PubMed ID: 12422691
    [No Abstract]   [Full Text] [Related]  

  • 10. Eplerenone (GD Searle & Co).
    Martin J; Krum H
    Curr Opin Investig Drugs; 2001 Apr; 2(4):521-4. PubMed ID: 11566010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of aldosterone in heart failure and the clinical benefits of aldosterone blockade.
    Dawson A; Davies JI; Struthers AD
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):29-36. PubMed ID: 15038411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone receptor blockade: a therapy resurrected.
    Sica DA
    Heart Dis; 2003; 5(2):85-8. PubMed ID: 12713674
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of aldosterone and aldosterone-receptor antagonists in heart failure.
    Khan NU; Movahed A
    Rev Cardiovasc Med; 2004; 5(2):71-81. PubMed ID: 15184841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardioprotective effect of aldosterone antagonists for ventricular remodeling].
    Tatsumi T; Matsubara H
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():524-9. PubMed ID: 16897886
    [No Abstract]   [Full Text] [Related]  

  • 15. [Eplerenone for treatment of heart failure].
    Yoshimura M
    Nihon Rinsho; 2007 May; 65 Suppl 5():153-8. PubMed ID: 17569313
    [No Abstract]   [Full Text] [Related]  

  • 16. Inspra improves survival for CHF patients.
    Wimett L; Laustsen G
    Nurse Pract; 2004 Jul; 29(7):56-9. PubMed ID: 15238861
    [No Abstract]   [Full Text] [Related]  

  • 17. [The EMPHASIS-HF study].
    Boccanelli A; Agostoni P
    G Ital Cardiol (Rome); 2011 May; 12(5):315-8. PubMed ID: 21593949
    [No Abstract]   [Full Text] [Related]  

  • 18. [More benefit in hypertension and high-grade reduction of the pump performance. Earlier beginning of therapy maximizes the benefit].
    MMW Fortschr Med; 2004 Oct; 146(43):59. PubMed ID: 15559525
    [No Abstract]   [Full Text] [Related]  

  • 19. Does eplerenone have a future in the management of hypertension in Europe?
    Gosse P; Macfadyen RJ
    J Hum Hypertens; 2006 Nov; 20(11):829-32. PubMed ID: 16915301
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of aldosterone antagonists in the cardiovascular diseases].
    Trzaska E; GumuĊ‚ka W; Makulska-Nowak HE
    Kardiol Pol; 2009 Jun; 67(6):667-71. PubMed ID: 19618325
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.